Bellevue Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197M | Buy |
|
|||||
|
2025
Q1 | $200M | Sell |
|
|||||
|
2024
Q4 | $196M | Sell |
|
|||||
|
2024
Q3 | $266M | Sell |
|
|||||
|
2024
Q2 | $278M | Sell |
|
|||||
|
2024
Q1 | $280M | Sell |
|
|||||
|
2023
Q4 | $300M | Sell |
|
|||||
|
2023
Q3 | $349M | Sell |
|
|||||
|
2023
Q2 | $386M | Sell |
|
|||||
|
2023
Q1 | $361M | Buy |
|
|||||
|
2022
Q4 | $317M | Sell |
|
|||||
|
2022
Q3 | $335M | Sell |
|
|||||
|
2022
Q2 | $331M | Sell |
|
|||||
|
2022
Q1 | $386M | Sell |
|
|||||
|
2021
Q4 | $393M | Buy |
|
|||||
|
2021
Q3 | $320M | Buy |
|
|||||
|
2021
Q2 | $350M | Buy |
|
|||||
|
2021
Q1 | $296M | Buy |
|
|||||
|
2020
Q4 | $293M | Buy |
|
|||||
|
2020
Q3 | $261M | Sell |
|
|||||
|
2020
Q2 | $285M | Sell |
|
|||||
|
2020
Q1 | $303M | Sell |
|
|||||
|
2019
Q4 | $304M | Sell |
|
|||||
|
2019
Q3 | $242M | Buy |
|
|||||
|
2019
Q2 | $260M | Buy |
|
|||||
|
2019
Q1 | $21.5M | Buy |
|
|||||
|
2018
Q4 | $19M | Buy |
|
|||||
|
2018
Q3 | $7.8M | Sell |
|
|||||
|
2018
Q2 | $7.19M | Sell |
|
|||||
|
2018
Q1 | $15.8M | Buy |
|
|||||
|
2017
Q4 | $14.4M | Buy |
|
|||||
|
2017
Q3 | $9.09M | Sell |
|
|||||
|
2017
Q2 | $8.81M | Sell |
|
|||||
|
2017
Q1 | $8.31M | Sell |
|
|||||
|
2016
Q4 | $5.97M | Sell |
|
|||||
|
2016
Q3 | $7.41M | Buy |
|
|||||
|
2016
Q2 | $5.68M | Hold |
|
|||||
|
2016
Q1 | $5.25M | Buy |
|